BIOHARVEST SCIENCES INC. APPOINTS DR. GEORGE GARIBALDI TO ITS SCIENTIFIC BOARD OF ADVISORS 2023 / Sam Chaloub BIOHARVEST SCIENCES INC. APPOINTS DR. GEORGE GARIBALDI TO ITS SCIENTIFIC BOARD OF ADVISORS Read More »
BIOHARVEST SCIENCES INC. ANNOUNCES LIVE QUARTERLY SHAREHOLDER UPDATE EVENT JANUARY 19, 2023, AT 2:00 PM E.T. 2023 / Sam Chaloub BIOHARVEST SCIENCES INC. ANNOUNCES LIVE QUARTERLY SHAREHOLDER UPDATE EVENT JANUARY 19, 2023, AT 2:00 PM E.T. Read More »
BIOHARVEST SCIENCES INC. 2022 CEO LETTER TO SHAREHOLDER PARTNERS 2022 / Sam Chaloub BIOHARVEST SCIENCES INC. 2022 CEO LETTER TO SHAREHOLDER PARTNERS Read More »
BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE THIRD TRANCHE OF CONVERTIBLE NOTES 2022 / Sam Chaloub BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF THE THIRD TRANCHE OF CONVERTIBLE NOTES Read More »
BIOHARVEST SCIENCES INC. PROJECTS 2023 REVENUE TO GROW 3.0X-3.5X TO A RANGE OF USD $17M-$20M 2022 / Sam Chaloub BIOHARVEST SCIENCES INC. PROJECTS 2023 REVENUE TO GROW 3.0X-3.5X TO A RANGE OF USD $17M-$20M Read More »
ROYAL EMERALD PHARMACEUTICALS PARTNERS WITH BIOHARVEST SCIENCES TO SUPPLY DISRUPTIVE CANNABIS SOLUTIONS TO COMPANIES CONDUCTING FDA-APPROVED MEDICAL RESEARCH 2022, Uncategorized / Sam Chaloub ROYAL EMERALD PHARMACEUTICALS PARTNERS WITH BIOHARVEST SCIENCES TO SUPPLY DISRUPTIVE CANNABIS SOLUTIONS TO COMPANIES CONDUCTING FDA-APPROVED MEDICAL RESEARCH Read More »
